Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder

Mostrar otras versiones (1)

BACKGROUND: Radiotherapy for muscle invasive bladder cancer (MIBC) aims to offer organ preservation without oncological compromise. Neo-adjuvant chemotherapy provides survival advantage; response may guide patient selection for bladder preservation and identify those most likely to have favourable r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafeez, S, Horwich, A, Omar, O, Mohammed, K, Thompson, A, Kumar, P, Khoo, V, Van As, N, Eeles, R, Dearnaley, D, Huddart, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430712/
https://www.ncbi.nlm.nih.gov/pubmed/25897675
http://dx.doi.org/10.1038/bjc.2015.109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430712/
https://www.ncbi.nlm.nih.gov/pubmed/25897675
http://dx.doi.org/10.1038/bjc.2015.109

Ejemplares similares